Brantas Abipraya Builds National Gene Bank in Bogor, Target Completion 2027
The government has begun construction of a National Gene Bank (Genomic Bank) facility at the Dr H Marzoeki Mahdi Hospital complex in Bogor. The project is projected to become Indonesia’s largest centre for storage and research of genetic material.
The facility is being constructed by state-owned construction company PT Brantas Abipraya (Persero). Brantas Abipraya Company Secretary Dian Sovana stated that the project presents higher construction complexity compared to typical building development.
“The Gene Bank development is designed with special standards to support genetic material storage systems, genomic research laboratories, and large-capacity data processing facilities,” Sovana said in a written statement on Monday (2 March 2026).
“This project requires not only technical precision, but also the implementation of strict security and environmental control systems to maintain the stability of biological samples in the long term,” she added.
The building will be equipped with precision temperature and humidity control systems to maintain the stability of stored genetic material. The facility will also feature layered security infrastructure and information technology support for managing genomic big data.
On a separate occasion, Bogor Mayor Dedie A Rachim expressed his appreciation for the development of the facility in his city. He made these remarks while inspecting the project site on 23 February 2026.
Brantas Abipraya’s involvement in building the National Gene Bank is described as part of the company’s support for the government’s priority agenda in the health sector. The company is not only constructing the physical structure of the building, but also ensuring that all stages of construction meet quality standards, work safety requirements, and project implementation timeliness.
Strategically, the presence of the National Gene Bank is viewed as an important foundation for strengthening the ecosystem for health research and innovation in Indonesia. The facility is also expected to encourage the development of genetics-based therapy.
“Brantas Abipraya is proud to be part of this strategic project. We believe the presence of Indonesia’s Gene Bank will strengthen the national health research and innovation ecosystem, whilst preparing Indonesia to enter the era of genomic-based precision medicine,” Sovana said.